http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111514135-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74ccc03b9160595016ddb907ed7ec5d3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2020-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6cffbd38d027e3153ce950ec4eb0a9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adb5622bf63109c08e21e76e8e3ceb4a
publicationDate 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111514135-A
titleOfInvention Use of compositions containing isoindolinone derivatives in the manufacture of medicaments for the treatment of phosphodiesterase-mediated diseases
abstract The present invention provides the use of a composition containing an isoindolinone derivative in preparing a medicament for treating phosphodiesterase, especially a disease mediated by phosphodiesterase 4. The inhibitory effects of various phosphodiesterase isoforms were significantly better than compound I. The results of animal experiments show that the composition of the present invention is significantly better than compound I in improving the histopathological parameters of the tibiotarsal joint in arthritic mice.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023015944-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113173878-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114644586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113173878-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113956189-A
priorityDate 2020-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496369
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6966
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11561674
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID241489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID421692
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID522509
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID747541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID569112
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403825
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID483996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID171115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414860340
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID140929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID242202
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29863

Total number of triples: 52.